inject

On June 8, 2017, the FDA requested that the drug-maker Endo Pharmaceuticals stop selling Opana ER – the extended-release version of Opana – because of “public health consequences of abuse.” It is the first time the agency has made efforts to pull an opioid from the market due to its highly addictive nature. [1]
According to the FBI, Opana ER is becoming a popular drug to crush, dissolve, and inject. An outbreak of HIV, Hepatitis C, and a serious blood disorder have been fueled by drug users sharing needles.

Life is about to get easier for people with Type 1 diabetes, now that the U.S. Food and Drug Administration (FDA) has approved a new automated insulin delivery system.
In Type 1 diabetes, the pancreas makes little or no insulin, so patients must inject themselves multiple times a day with insulin, or use an insulin pump. It can be easy to inject too much or too little of the hormone, depending on what and how much a person eats, and if they exercise. [1]